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Rotavirus is a major cause of severe, dehydrating childhood diarrhea. VP7, the rotavirus outer capsid glycoprotein, is a
target of protective antibodies and is responsible for the calcium-dependent uncoating of the virus during cell entry. We have
purified, characterized, and crystallized recombinant rhesus rotavirus VP7, expressed in insect cells. A critical aspect of the
purification is the elution of VP7 from a neutralizing monoclonal antibody column by EDTA. Gel filtration chromatography and
equilibrium analytical ultracentrifugation demonstrate that, in the presence of calcium, purified VP7 trimerizes. Trimeric VP7
crystallizes into hexagonal plates. Preliminary X-ray analysis suggests that the crystal packing reproduces the hexagonal
component of the icosahedral lattice of VP7 on triple-layered rotavirus particles. These data indicate that the rotavirus outer
capsid assembles from calcium-dependent VP7 trimers and that dissociation of these trimers is the biochemical basis for
EDTA-induced rotavirus uncoating and loss of VP7 neutralizing epitopes. © 2000 Academic PressKey Words: rotavirus; VP7; calcium; trimerization; assembly; purification; crystallization; uncoating; capsid; analytical
ultracentrifugation.INTRODUCTION
Rotavirus is the most important cause of severe, de-
hydrating childhood diarrhea worldwide (Committee,
1986). Two proteins, VP4 and VP7, are exposed on the
surface of the triple-layered, icosahedral virion. VP4
forms spikes and is activated by trypsin cleavage to
function as a fusion protein for cell entry (Estes et al.,
1981; Shaw et al., 1993; Yeager et al., 1994). VP7 is a
calcium-binding glycoprotein that forms a thin outer layer
with a T 5 13 icosahedral lattice (Dormitzer and Green-
berg, 1992; Prasad and Chiu, 1994; Yeager et al., 1990). In
a reconstructed image from electron cryomicroscopy,
VP7 appears to form trimers on the surface of the virion
(Yeager et al., 1990). Both VP4 and VP7 are targets of
neutralizing and protective antibodies against rotavirus
(Hoshino et al., 1985; Mackow et al., 1988a,b; Offit et al.,
1986).
During viral replication, VP7 is retained in the lumen of
the endoplasmic reticulum (ER), despite the removal of
its only apparent transmembrane domain by signal
cleavage (Clarke et al., 1995; Maass and Atkinson, 1994).
During viral assembly, the rotavirus double-layered par-
ticle buds from the low-calcium environment of the cyto-
plasm into the high-calcium environment of the ER lumen
and acquires a transient envelope. The mature triple-1 To whom correspondence should be addressed. Fax: (617) 738-
184. E-mail: dormitze@crystal.harvard.edu.
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420layered virion is formed as the newly assembled outer-
most protein layer displaces the transient envelope. Dou-
ble-layered particle budding and outer layer assembly
are mediated by NSP4, a virally encoded nonstructural
glycoprotein, which is anchored in the ER membrane,
increases the permeability of the ER membrane to cal-
cium, and forms a complex with double-layered particles,
VP4, and VP7 (Maass and Atkinson, 1990; Au et al., 1993;
Tian et al., 1995). When the ER is depleted of calcium,
rotavirus maturation is blocked at the enveloped inter-
mediate stage, and the outer layer does not form
(Poruchynsky et al., 1991).
During cell entry, the rotavirus triple-layered particle
uncoats, losing VP4 and VP7, and the transcriptionally
active double-layered particle is delivered into the cyto-
plasm. This membrane penetration event occurs in the
context of passage from the high-calcium extracellular
environment to the low-calcium environment of the cyto-
plasm. Raising the intracellular calcium concentration
blocks entry (Ludert et al., 1987).
The outermost layer of rotavirus contains calcium
(Shahrabadi et al., 1987). In vitro, calcium chelation trig-
gers uncoating of the triple-layered particle (Cohen et al.,
1979). The sensitivity of virions to low concentrations of
calcium has been linked genetically to VP7 (Gajardo et
al., 1997; Ruiz et al., 1996). Expressed VP7, in the absence
of other rotavirus proteins, undergoes an antigenic
change upon calcium chelation, losing its ability to bind
neutralizing monoclonal antibodies (mAbs) (Dormitzer
and Greenberg, 1992).
421ROTAVIRUS VP7 TRIMERSThese findings suggest that formation of the outer
layer during viral assembly and loss of the outer layer
during cell entry are mediated by a calcium-dependent
conformational change in VP7. During viral replication,
these changes take place in the context of membrane
disruption.
Recombinant rhesus rotavirus (RRV) VP7 has been
expressed in insect cells by a baculovirus vector (Fiore
et al., 1995). We have developed a rapid and gentle
procedure for purifying this recombinant VP7 in quanti-
ties sufficient for detailed biochemical and structural
study. We have analyzed purified VP7 by circular dichro-
ism spectroscopy (CD), gel filtration chromatography,
and equilibrium analytical ultracentrifugation to deter-
mine the biochemical basis for its calcium-dependent
antigenic change.
RESULTS
Sequence of the RRV gene segment 9 clone
We determined the DNA sequence (GenBank Acces-
sion No. AF295303) of the cDNA clone of RRV gene
segment 9 mRNA that was used by Fiori and co-workers
(1995) to construct the recombinant baculovirus. The
sequence, after PCR modification of the 59 end as de-
scribed (Fiore et al., 1995), is predicted to encode full-
length VP7, including the amino-terminal signal peptide.
VP7 encoded by the modified gene has three amino acid
differences from the protein encoded by a published
sequence of pooled RRV gene segment 9 mRNA
(Mackow et al., 1988a). The changes are Cys to Phe at
position 32, Ala to Thr at position 171, and Asn to Tyr at
position 324. Each change replaces an amino acid en-
coded by the pooled mRNA with the corresponding res-
idue in a consensus sequence of VP7s from G-type 3
rotaviruses (Nishikawa et al., 1989).
Purification of VP7
VP7 was purified from recombinant baculovirus-in-
fected Sf9 cell cultures as described under Materials and
Methods. The key step in the purification was specific
binding of VP7 to a mAb 159 column and its subsequent
specific elution by EDTA (Fig. 1). When used in a single
column purification, the mAb 159 column alone purified
VP7 to greater than 95% (Fig. 1B, lanes 16–20) from a
clarified cell culture medium in which VP7 made up a
minor portion of the total protein (Fig. 1B, lane “PRE”). A
con A affinity chromatography step was added prior to
the mAb 159 column to prevent fouling of the antibody
column with cell culture constituents. Unlike the antibody
column, the con A column can be cleaned with relatively
harsh reagents and is commercially available. A gel
filtration step was added after the mAb 159 column to
eliminate heterogeneity in the VP7 preparation that was
apparent by gel filtration (see below) but not by Coom-
assie-stained SDS–PAGE.Two observations determined the choice of buffers
used in the procedure. First, in the presence of EDTA,
VP7 has a tendency to aggregate (see below). To mini-
mize the amount of time that VP7 spent in the presence
FIG. 1. Elution of VP7 from a mAb 159 column with an EDTA gradient.
VP7 from clarified Sf9 cell culture medium was bound to the column
and then eluted with a gradient from TNC to a buffer in which CaCl2
was replaced by 20 mM EDTA. (A) Chromatogram during washing and
elution. Solid line, A280 trace; dashed line, EDTA gradient; fraction
numbers are above abscissa. The chromatogram was traced and
scaled using Adobe Photoshop 5.0 and Adobe Illustrator 8.0. (B) Coo-
massie-stained 10–20% SDS–PAGE of eluted fractions. Lanes contain
the following samples: MW, molecular weight standards (in kD); PRE,
clarified cell culture medium; FT, flow-through; numbers refer to the
eluate fractions indicated on the chromatogram. The major band in
lanes PRE, FT, 1, and 6 derives from FBS in the baculovirus inoculum.
The apparent MW of the VP7 band in lanes 16 to 20 is approximately 38
kD. The image was produced using Adobe Photoshop 5.0.of excess EDTA, fractions from the mAb 159 column were
collected in tubes containing 0.5 fraction vol. of buffer
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422 DORMITZER, GREENBERG, AND HARRISONwith 5 mM calcium. Second, in the presence of calcium,
VP7 tends to stick to surfaces; this tendency was less
marked in 0.1 3 TNC than in 13 TNC (data not shown).
Therefore, prior to concentration by ultrafiltration, VP7
was dialyzed against 0.1 3 TNC.
This procedure was effective at purifying VP7 from
either Sf9 cell culture medium or lysed Sf9 cells. VP7
purified from a cell lysate produced a slightly more dif-
fuse band by Coomassie-stained SDS–PAGE than did
VP7 purified from the cell culture medium (not shown).
No other significant differences were observed. The
yield of purified VP7 was higher from the medium, with
0.25 to 0.5 mg obtained per liter of initial cell culture.
N-terminal sequencing of purified VP7
The identity of the purified protein was confirmed by
amino acid sequencing. Efforts to determine the N-ter-
minal sequence of the purified protein showed that the
N-terminus was blocked. In rotavirus-infected cells, VP7
undergoes signal cleavage between residues Ala50 and
Gln51, and the resulting N-terminus is blocked by pyro-
glutamic acid (Stirzaker et al., 1987). Trypsin digestion of
the purified protein produced a fragment with an appar-
ent MW by SDS–PAGE of approximately 13.1 kDa and
with an N-terminal sequence of “LVIT,” corresponding to
amino acids 224–227 of the predicted RRV VP7 amino
acid sequence.
Mass spectroscopy of purified VP7
MALDI time-of-flight mass spectroscopy of purified
recombinant VP7 yielded a main species with a MW of
FIG. 2. CD spectroscopy of VP7. A reconstructed spectrum (Fit VP7)
of either 1 mM CaCl2 (Ca ellipticity) or 1 mM EDTA (ED ellipticity). Ea
andwidth. Spectrum reconstructed using CONTIN (Provencher and G32,154 (664) and a minor species with a MW of 31,386
(663). The predicted MW of RRV VP7 prior to signalcleavage is 36,992. After signal cleavage and modifica-
tion of the N-terminus, but prior to glycosylation, the
predicted MW of RRV VP7 is 31,229. RRV VP7 has one
predicted N-linked glycosylation site at Asn69 (Mackow
et al., 1988a). The mass spectroscopy results are con-
sistent with signal sequence cleavage, N-terminal mod-
ification, and glycosylation of the purified recombinant
VP7.
Circular dichroism spectroscopy of VP7 in the
presence of CaCl2 and EDTA
To evaluate the possibility that calcium chelation in-
uced a major rearrangement of secondary structure,
D spectra of VP7 were obtained from 200 to 240 nm in
he presence of either 1 mM CaCl2 or 1 mM EDTA. No
significant differences were observed between the two
spectra (Fig. 2). The data sets obtained with VP7 in
CaCl2- and EDTA-containing buffers were averaged, and
he resulting data set was analyzed with the CONTIN
oftware package (Provencher and Glockner, 1981). A
pectrum representing 19% a-helix, 42% b-pleated sheet,
19% b-turn, and 20% disordered conformations gave an
excellent fit to the experimental data (Fig. 2).
Gel filtration chromatography of VP7 in the presence
of CaCl2 and EDTA
The gel filtration profiles of VP7 in the presence of
CaCl2 and EDTA were very different (Fig. 3). Gel filtration
of mAb 159-purified VP7 on a Superdex 200 column
equilibrated in TNC produced two peaks. The major peak
had a K AV of 0.288, corresponding to an apparent MW of
rimposed on data sets collected at room temperature in the presence
point is averaged from 12 measurements of 0.5 s each with a 1-nm
r, 1981).is supe141 kDa; the minor peak had a K AV of 0.466, correspond-
ing to an apparent MW of 46 kDa (Fig. 3A). The ratio of
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423ROTAVIRUS VP7 TRIMERSapparent MWs of the major and minor peaks is 3.1 to 1.
Protein harvested from the major calcium-associated
VP7 peak did not change its gel filtration mobility after
storage (not shown).
Gel filtration of mAb 159-purified VP7 on a Superdex
200 column equilibrated in TNE produced a major peak
with a KAV of 0.443, corresponding to an apparent MW of
7 kDa (Fig. 3B). At least four other peaks of VP7 eluted
t lower volumes, including a peak in the void volume.
epeat gel filtration of protein harvested from the major
DTA-associated peak demonstrated an increasing pro-
ortion of higher MW complexes; repeat gel filtration of
rotein harvested from the high MW peaks demon-
trated a relatively small amount of monomer (not
hown). Gel filtration of VP7 in the presence of 5 mM
FIG. 3. Gel filtration chromatography of VP7. Solid lines, A280; dashed
lines, calibration curves; circles, elution volumes of MW markers. (A)
Chromatogram from a Superdex 200 Hi-Load 16/60 gel filtration column
equilibrated in TNC. Sample is the eluate from a mAb 159 column
collected in tubes containing 0.5 fraction volumes of 5 mM CaCl2. (B)
hromatogram from a Superdex 200 HR 10/30 gel filtration column
quilibrated in TNE. Sample is the eluate of a mAb 159 column col-
ected without adding excess calcium. Chromatograms were traced
nd scaled using Adobe Photoshop 5.0 and Adobe Illustrator 8.0.gCl2 (not shown) yielded a pattern similar to that ob-
tained in the presence of EDTA.Analytical ultracentrifugation of VP7
VP7 from the major gel filtration peak in TNC was
studied by equilibrium analytical ultracentrifugation (Fig.
4). When the equilibrium protein distributions from five
starting concentrations were fit separately to models of
single nonassociating proteins, the weight-average ap-
parent MW increased from 79.4 kDa for the most dilute
sample (51 mg/ml) to 96.2 kDa for the most concentrated
sample (179 mg/ml). This increase suggested an associ-
ating system in dynamic equilibrium, with more oligo-
meric VP7 present at higher VP7 concentrations. There-
fore, pooled data from the five samples were fit to mod-
els of a self-associating protein. The data predicted a
34.3 kDa protein that trimerizes with an association con-
stant of approximately 2 3 103. In Fig. 4, an A280 vs radius
curve predicted by this model is superimposed on one of
the five data sets. The residuals between the data and
the fit curve show a random scatter, demonstrating lack
of evidence for either aggregation or nonideality in the
sample.
Crystallization and preliminary X-ray analysis of VP7
VP7 was crystallized in the presence of calcium by the
vapor diffusion method, as described under Materials
and Methods. CaCl2 concentration was a critical param-
eter. With less than 0.05 mM CaCl2 in the crystallization
uffer, crystals did not form reliably; with greater than 0.3
M CaCl2, many microcrystals formed. CsCl was in-
cluded in the crystallization buffer because salts of alkali
metals of high atomic mass promoted formation of iso-
lated plates, while salts of alkali metals of lower atomic
mass promoted formation of clustered plates and nee-
dles. Plates with partial or full hexagonal outline formed
after 2 to 5 days of incubation at 30°C. These plates
reached a maximum size of 640 by 250 mm but remained
less than 25 mm thick. There were no significant differ-
FIG. 4. Equilibrium analytical ultracentrifugation of VP7. A280 vs radius
lot of 100 mg/ml VP7 in TNC following centrifugation at 9000 rpm at
4°C for 85 h. This protein distribution was stable over 30 h of mea-
surements. The curve, fit to five data sets of VP7 at different concen-
trations, is the theoretical distribution of a 34.3-kDa protein with a K A3
of 1957 and a partial specific volume of 0.7223 ml/g in a buffer with a
density of 1.004 g/ml. The baseline offset is 0.005 A280.
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424 DORMITZER, GREENBERG, AND HARRISONences in morphology between crystals of native and
deglycosylated VP7.
X-ray diffraction with the incident beam perpendicular
to the plane of the plates extended to spacings of 2.9 Å
or smaller. The diffraction pattern revealed a well-or-
dered hexagonal lattice in the plane of the plates with
a 5 b 5 114.0 Å. X-ray beams parallel to the plane of
he plates were diffracted with a highly elongated spot
hape, except for a well-defined row of spots for reflec-
ions with h 5 k 5 0. This row of spots indicated an
nterplanar spacing of 78.5 Å.
DISCUSSION
We have developed a rapid method for purifying re-
ombinant VP7 expressed in Sf9 cells. The binding of
eutralizing mAbs to recombinant rotavirus VP7 is calci-
m-dependent (Dormitzer and Greenberg, 1992). This
bservation suggested a straightforward and gentle pu-
ification strategy: bind expressed VP7 to a neutralizing
Ab in the presence of calcium and elute it with EDTA.
similar approach has been used to purify clotting
actors (Rudolph et al., 1997; Takebe et al., 1995). MAb
59 was selected for constructing the antibody affinity
olumn because, in an ELISA format, it bound recombi-
ant VP7 more stably than did other neutralizing mAbs
ested (Dormitzer et al., 1992). When used as a single
hromatographic step, this antibody column yielded 0.25
o 0.5 mg of .95% pure VP7 per liter of starting insect cell
ulture (Fig. 1). This scale of production is sufficient to
upport both biochemical and X-ray crystallographic
nalysis.
In addition to simplicity and rapidity, this purification
rotocol has the advantage that specific calcium-depen-
ent binding and release from mAb 159 selects for prop-
rly folded, mature VP7. When disulfide bond formation is
locked by DTT treatment of rotavirus-infected cells, neu-
ralizing epitopes do not form (Svensson et al., 1994).
imilarly, a membrane-associated form of VP7 that is a
recursor to mature VP7 in rotavirus-infected cells was
ot recognized by a neutralizing mAb (Kabcenell et al.,
988). Therefore, forms of VP7 without mature disulfide
onds and the membrane-associated form of VP7 do not
ontaminate the preparations.
A reconstruction of the rotavirus triple-layered particle
ased on electron cryomicroscopy indicates that VP7 is
rranged on the surface of the virion in trimers (Yeager et
l., 1990). Gel filtration chromatography demonstrates
hat purified calcium-bound VP7 also forms trimers in
olution (Fig. 3A). In the presence of calcium, VP7 sep-
rates into major (141 kDa) and minor (46 kDa) peaks.
he lack of VP7 eluting after the minor peak and the 3.1
o 1 ratio of apparent MWs of the major and minor peaks
uggest that they contain soluble trimeric and mono-
eric VP7, respectively. The nonglobular shape of VP7,
pparent in electron cryomicroscopy-based reconstruc-
n
Tions of the virion (Prasad and Chiu, 1994; Yeager et al.,
990), probably accounts for the difference between the
pparent monomer MW of VP7 by gel filtration and its
ctual MW (32 kDa) determined by mass spectroscopy
nd calculated from its amino acid sequence.
Equilibrium analytical ultracentrifugation of calcium-
ound VP7 from the major gel filtration peak confirmed
he presence of trimers. The pooled data from samples
ith a range of VP7 concentrations fit a model of a
4-kDa protein in dynamic equilibrium between mono-
er and trimer. The estimate of monomer MW in this
odel is in good agreement with the true MW of the
ubunit. Attempts to fit the ultracentrifugation data to
onomer–dimer or monomer–tetramer models of asso-
iation did not yield correct predictions of monomer MW.
Circular dichroism spectroscopy and gel filtration
hromatography clarify the biochemical basis for EDTA-
nduced virus uncoating and loss of VP7 neutralizing
pitopes. There were no significant differences between
he CD spectra of soluble VP7 in the presence of calcium
r EDTA (Fig. 2). Therefore, a major calcium chelation-
nduced change in VP7 secondary structure is unlikely. In
ontrast, gel filtration chromatography demonstrated a
ajor EDTA-induced change in the oligomeric state of
P7. In the presence of EDTA, there was a major peak
ith an apparent MW of 47 kDa (monomeric VP7) and a
ariety of higher molecular weight forms, which in-
reased in proportion over time (Fig. 3B). These data
ndicate that calcium-free VP7 is predominantly mono-
eric, but aggregates over time.
X-ray crystallography has revealed two distinct struc-
ural roles for calcium in viral capsids. In polyoma vi-
uses, such as SV40, calcium helps to bind together
djacent pentameric capsomeres by stabilizing tethering
trands between them (Liddington et al., 1991). In a
umber of plant viruses, such as tomato bushy stunt
irus (TBSV), calcium binds together proteins within each
rimeric capsomer by complexing negative charges at
he interfaces of adjacent proteins (Hogle et al., 1983).
he biochemical data presented here indicate that cal-
ium binds within VP7 trimers, probably assuming a
tructural role similar to that observed in the TBSV cap-
id.
The specificity of neutralizing mAbs for calcium-asso-
iated recombinant VP7 (Dormitzer and Greenberg, 1992)
uggests that they specifically bind trimeric VP7. Neutral-
zation escape mutant analysis shows that VP7’s neutral-
zing epitopes are formed by amino acids that are widely
paced in VP7’s primary sequence (Dyall-Smith et al.,
986; Mackow et al., 1988a; Taniguchi et al., 1988). These
esidues may, in fact, be contributed by adjacent VP7
ubunits at calcium-stabilized interfaces within trimers.
alcium chelation disrupts complexes of neutralizing
Abs and VP7 alone but not complexes of VP7-specificeutralizing mAbs and virions (Dormitzer et al., 1994).
hus, neutralizing mAb binding of VP7 on the virion may
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425ROTAVIRUS VP7 TRIMERSprevent the calcium chelation-induced dissociation of
VP7 trimers.
Under standard biochemical conditions, neither gel
filtration chromatography nor analytical ultracentrifuga-
tion reveals any evidence of higher order assemblies of
calcium-bound, trimeric VP7. Similarly, electron micros-
copy of VP7 after EDTA treatment and negative staining
with uranyl acetate (not shown) reveal no evidence for
any ordered capsid-, sheet-, or tube-like structures, such
as those observed with recombinant rotavirus VP6 (Estes
et al., 1987; Petitpas et al., 1998). In contrast, under
onditions of supersaturation, calcium-associated VP7
orms hexagonal plates. X-ray diffraction reveals a two-
imensional hexagonal unit cell length of 114 Å. Electron
ryomicroscopy-based reconstructions of rotavirus par-
icles show that the distance between 6-coordinated
ositions in the T 5 13 icosahedral lattice is 110 to 120
at the radius of the VP7 layer (Prasad and Chiu, 1994;
eager et al., 1990). It is, therefore, likely that the lateral
packing of VP7 is similar in the crystal and virion lattices.
The thickness of the VP7 layer on the virion is approx-
imately 30 Å (Prasad and Chiu, 1994; Yeager et al., 1990).
The interplanar spacing of 78.5 Å in the crystals can,
therefore, accommodate two layers, probably tail-to-tail
(or head-to-head). These two-layer sheets must pack
with perfect orientational register to yield the well-or-
dered hexagonal lattice observed by X-ray diffraction, but
with considerable translational disorder parallel to the
plane of the sheets. A hexagonal pattern of ridges and
grooves can give rise to this sort of packing.
These experiments demonstrate that calcium-stabi-
lized VP7 trimers are the basic building block of the outer
layer of the rotavirus virion. VP7 can trimerize without
binding to the trimeric VP6 pillars that make up the
surface of the double-layered particle. Furthermore,
these experiments indicate that dissociation of VP7 tri-
mers is the biochemical basis for rotavirus uncoating
and the loss of VP7 neutralizing epitopes triggered by
calcium chelation. The tendency of VP7 to form well-
ordered arrays should permit a high-resolution structure
determination, either using X-ray diffraction by VP7 crys-
tals with improved three-dimensional order or using
electron diffraction by two-dimensional VP7 crystals.
MATERIALS AND METHODS
Cells, viruses, and antibodies
Sf9 insect cells were grown in Sf900II (Gibco BRL) and
Excell 420 (JRH Biosciences) serum-free media. The re-
combinant baculovirus, which expresses RRV VP7
(G-type 3), was constructed by Fiore and coworkers
(Fiore et al., 1995). Baculovirus was propagated as pre-
viously described (Willis et al., 1998). Baculovirus stocks
were stabilized with 5–10% fetal bovine serum (FBS).
Neutralizing mAb 159 has been previously described
(Greenberg et al., 1983) and was produced as a hybrid-
p
2oma culture supernatant. The hybridoma was grown in
Hybridoma–SFM supplemented with OptiMAb enhancer
(Gibco BRL).
Production of infected cell lysates and culture
supernatants
Infection of Sf9 cells grown in spinner flasks with
baculovirus was performed as previously described (Wil-
lis et al., 1998). To recover VP7 from the medium of the
infected cells, the medium was clarified by centrifugation
at 2700 g for 10 min at 4°C and, in some preparations, by
filtration through a 0.2-mM pore-size polyethylsulfone fil-
ter. Na-azide was added to 0.02%, and benzamidine was
added to 2.5 mM. Alternatively, VP7 was released from
the cell pellet by a single freeze-thaw in a lysis buffer
consisting of phosphate-buffered saline (PBS), 1% Triton
X-100, 5% glycerol, 0.02% Na-azide, 2.5 mM benzamidine,
and 1 mM phenylmethylsulfonyl fluoride. The cell lysate
was clarified by centrifugation at 235,000 g for 2 h at 4°C
and diluted 10-fold with PBS, 0.02% Na-azide, and 0.5
mM benzamidine.
Preparation of the mAb 159 column
MAb 159 was partially purified by ammonium sulfate
precipitation as previously described (Harlow and Lane,
1988). The antibody was then bound to Poros 20G beads
(Perceptive Biosystems) in PBS, the beads were washed,
and bound antibody was cross-linked to the beads using
dimethylpimelimidate, as previously described (Park-
house, 1984).
Purification of VP7
The clarified cell culture supernatant or cell lysate was
passed over concanavalin A (Con A)–Sepharose beads
(Amersham Pharmacia Biotech) at 4°C after equilibration
of the column with 20 mM Tris, pH 8.0, 100 mM NaCl, 1
mM CaCl2 (TNC). After the column was washed with
TNC, VP7 was eluted at room temperature with TNC, 0.8
M methyl a-D-mannopyranoside.
The Con A column eluate was passed over a mAb 159
olumn that was mounted on a BioCad Sprint chroma-
ography station (Perceptive Biosystems) and equili-
rated with 20 mM Tris, pH 8.0, 50 mM NaCl, 0.1 mM
aCl2 at room temperature. The column was washed
with equilibration buffer, and VP7 was eluted with a step
gradient to 20 mM Tris, pH 8.0, 50 mM NaCl, 1 mM EDTA.
Eluted fractions were collected in tubes containing 0.5
fraction volumes of 20 mM Tris 8.0, 50 mM NaCl, 5 mM
CaCl2.
VP7 eluted from the mAb 159 column was buffer ex-
hanged into 0.13 TNC by dialysis and concentrated by
ltrafiltration (Amicon). Gel filtration chromatography was
erformed on an FPLC system at 4°C using Superdex
00 Hi-Load 16/60 or HR 10/30 gel filtration columns
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426 DORMITZER, GREENBERG, AND HARRISON(Amersham Pharmacia Biotech) equilibrated in 20 mM
Tris, pH 8.0, 100 mM NaCl, 1 mM EDTA (TNE) or in TNC.
The above is an optimized VP7 purification protocol.
Minor variations were used to produce some of the VP7
used in the experiments described in this report.
Quantitation of VP7
The concentration of VP7 was determined by spectro-
photometry at 280 nm using a molar extinction coeffi-
cient of 61,270 M21 cm21, calculated from the predicted
mino acid sequence. For more accurate quantitation of
he samples used in circular dichroism spectroscopy, the
P7 samples were diluted with 3 volumes of 8 M gua-
idine–HCl prior to spectrophotometry.
mino acid sequencing
For N-terminal sequencing, 800 mg/ml of VP7 was
digested with 2.5 mg/ml of L-(tosylamido 2-phenyl) ethyl
hloromethyl ketone-treated trypsin (Worthington Bio-
hemical) for 2 h at room temperature in TNE. The di-
estion was stopped with 1 mM PMSF. Digested frag-
ents were separated by SDS–PAGE and electroblotted
nto Sequi-Blot polyvinylidene difluoride membrane (Bio-
ad). Coomassie-stained bands were excised, and
-terminal sequence was obtained at the Tufts Protein
hemistry Facility (Boston).
ass spectroscopy
A VP7 sample for mass spectroscopy was prepared by
icrodialysis against 1 mM CaCl2. Matrix-assisted laser
desorption (MALDI) time-of-flight mass spectroscopy
was performed at the W. M. Keck Foundation Biotechnol-
ogy Resource Laboratory at Yale University using a sina-
pinic acid matrix. The sample was calibrated using bo-
vine serum albumin as a standard. The accuracy of
measurement is estimated at 60.002%.
Circular dichroism spectroscopy
VP7 samples for CD were buffer exchanged by micro-
dialysis into 20 mM boric acid–NaOH, pH 8.0, 100 mM
NaF, with either 1 mM CaCl2 or 1 mM EDTA. Circular
dichroism was measured with an Aviv model 62DS CD
spectrometer using a 1-mm path length quartz curvette.
Calibration of gel filtration columns
Superdex 200 gel filtration columns were calibrated
using a set of globular protein standards (Amersham
Pharmacia Biotech) consisting of ferritin (440 kDa), aldo-
lase (158 kDa), ovalbumin (43 kDa), and RNase A (13.7
kDa). Calibration curves were constructed by plotting K AV
vs ln(MW), where K AV 5 (V e 2 V o)/(V t 2 V o). V e is the
easured elution volume of the markers; V o, the void
olume of the column, was determined by gel filtration of
lue dextran; and V t, the total column volume, was spec-
t
tified by the manufacturer (Amersham Pharmacia Bio-
tech).
Analytical ultracentrifugation
Samples for analytical ultracentrifugation were micro-
dialyzed against TNC. The diasylate was used as a blank
and as a diluent for centrifugation. Analytical centrifuga-
tion was performed using an Optima XL-A analytical
ultracentrifuge (Beckman Coulter). Absorbance data
were obtained at 280 nm. Each sample was centrifuged
at 9000 rpm in an AN-60 Ti rotor with six chamber
centerpieces at 4°C for 85–91 h. The attainment of equi-
librium was confirmed by comparing absorbance curves
obtained at 6-h intervals. The specific volume of VP7 was
calculated based on the amino acid composition of VP7,
the carbohydrate content of VP7 (estimated by compar-
ison of the predicted and mass spectroscopy-deter-
mined monomer MW of VP7), and published data (McRo-
rie and Voelker, 1993). The density of TNC at 4°C was
calculated from published data (McRorie and Voelker,
1993).
Crystallization of VP7
For crystallization, VP7 eluted from the mAb 159 col-
umn was dialyzed against 0.13 TNC, concentrated to 4
to 10 mg/ml using Centricon and Centriprep ultrafiltration
units (Amicon), and gel filtered using Superdex 200 in
0.13 TNC. In some cases, the dialyzed, concentrated
protein was incubated with glycopeptidase F (provided
by Dr. Don Wiley) in a 1:460 to 1:1400 molar ratio for 2 h
at 30°C prior to gel filtration. Crystals were obtained by
the hanging-drop vapor diffusion method. VP7 at 6–8
mg/ml was mixed with an equal volume of 12–15% poly-
ethylene glycol 10,000 MW (Hampton Research), 100–
375 mM CsCl, 100 mM Pipes, pH 6.1, 0.1 mM CaCl2, 0.02%
sodium azide, 0.1 mM benzamidine in 2- to 8-ml drops.
he crystallization trays were incubated at room temper-
ture or at 30°C. Prior to freezing in liquid nitrogen, the
rystals were soaked first in a solution in which CsCl
as replaced with an equal concentration of NaCl and
hen in an equivalent solution containing 22–25% glyc-
rol.
-ray analysis
X-ray diffraction patterns of frozen crystals were ob-
ained at the Cornell High Energy Synchrotron Source,
eamline A1, with a Quantum-4 charge-coupled device
etector (Area Detector Systems Corporation).
olecular biology
Plasmid DNA for sequencing was prepared using Qia-
en plasmid Midi kits. DNA oligonucleotide primer syn-hesis and plasmid DNA sequencing were performed by
he Howard Hughes Medical Institute Biopolymer Facility
aE
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427ROTAVIRUS VP7 TRIMERS(Boston). SDS–PAGE, Coomassie staining, and electrob-
lotting were performed using established techniques
(Sambrook et al., 1989). SDS–PAGE standards were ob-
tained from Gibco BRL.
Computation
Image-plate X-ray diffraction data were processed us-
ing MOSFLM (Leslie, 1998). CD data were analyzed us-
ing CONTIN software, which uses a ridge regression
algorithm to derive secondary structure predictions from
CD spectra (Provencher and Glockner, 1981). A set of 16
proteins of known structure and polyglycolic acid were
used as a comparison database (Sreerama and Woody,
1994). DNA and amino acid sequence data were ana-
lyzed using the Lasergene suite of sequence analysis
software (DNAstar). Ultracentrifugation data were ana-
lyzed using Optima XL-A software version 3.0 (Beckman
Instruments, Inc.) and Origin version 3.78 (Microcal Soft-
ware). This software fits ultracentrifugation data to the
model
A r 5 A0,1exp@HM~x
2 2 x 0
2!#
1 ~A0,1!
NK exp@HNM~x 2 2 x 0
2!# 1 E,
where A r is the absorbance at radius x; A 0,1 is the
absorbance of the monomer at the reference radius x 0;
H is a constant to account for the specific volume of the
protein, the solvent density, the angular velocity of the
rotor, and the temperature; M is the monomer molecular
weight; N is the stoichiometry of the association; K is the
ssociation constant; and E is the baseline offset. A 0,1 is
constrained to be greater than 0.
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